These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15908727)

  • 1. [Modern trends in the treatment of patients with atrial fibrillation].
    Abuladze G; Mamamtavrishvili N; Jashi I; Kantaria D; Ambroladze N
    Georgian Med News; 2005 Apr; (121):59-61. PubMed ID: 15908727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation: rhythm control offers no advantage over rate control for some, but not all.
    Li YB; Hu CL; Liu J; Chen YX; Qu Z; Xu JL; Chen JB; Wan J; Tang QZ; Huang CX
    Med Hypotheses; 2007; 69(1):206-8. PubMed ID: 17011138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of atrial fibrillation in the elderly.
    Aronow WS
    Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern concepts of atrial fibrillation.
    Chun JG; Brodsky MA; Allen BJ
    Herz; 1993 Feb; 18(1):67-75. PubMed ID: 8454254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of atrial fibrillation.
    Hersi A; Wyse DG
    Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation: cure or treat?
    Forleo GB; Tondo C
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):187-96. PubMed ID: 19443515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
    Aronow WS
    Cardiol Rev; 2008; 16(4):181-8. PubMed ID: 18562808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation.
    Kosior DA; Stawicki S; Wozakowska-Kapłon B; Szulc M; Opolski G; Rabczenko D
    Kardiol Pol; 2005 Jul; 63(7):36-47; discussion 48-9. PubMed ID: 16136427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
    Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
    Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
    Curtis AB; Seals AA; Safford RE; Slater W; Tullo NG; Vidaillet H; Wilber DJ; Slee A
    Am Heart J; 2005 Feb; 149(2):304-8. PubMed ID: 15846269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Flaker GC; Belew K; Beckman K; Vidaillet H; Kron J; Safford R; Mickel M; Barrell P;
    Am Heart J; 2005 Apr; 149(4):657-63. PubMed ID: 15990749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation: goals of therapy and management strategies to achieve the goals.
    Padanilam BJ; Prystowsky EN
    Cardiol Clin; 2009 Feb; 27(1):189-200, x. PubMed ID: 19111774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion.
    Naji F; Suran D; Kanic V; Vokac D; Sabovic M
    Med Sci Monit; 2009 Sep; 15(9):CR494-8. PubMed ID: 19721402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
    Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study).
    Freudenberger RS; Wilson AC; Kostis JB;
    Am J Cardiol; 2007 Jul; 100(2):247-52. PubMed ID: 17631079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized evaluation of right atrial ablation after left atrial ablation of complex fractionated atrial electrograms for long-lasting persistent atrial fibrillation.
    Oral H; Chugh A; Good E; Crawford T; Sarrazin JF; Kuhne M; Chalfoun N; Wells D; Boonyapisit W; Gadeela N; Sankaran S; Kfahagi A; Jongnarangsin K; Pelosi F; Bogun F; Morady F
    Circ Arrhythm Electrophysiol; 2008 Apr; 1(1):6-13. PubMed ID: 19808388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation.
    Holmqvist F; Stridh M; Waktare JE; Sörnmo L; Olsson SB; Meurling CJ
    Eur Heart J; 2006 Sep; 27(18):2201-7. PubMed ID: 16956916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.